Cardinal Healthcare recalls RIVASTIGMINE TRANSDERMAL SYSTEM
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
- Products
-
- RIVASTIGMINE TRANSDERMAL SYSTEM
- Company
- Cardinal Healthcare
- Where it was sold
-
Nationwide USA
Nationwide
- Units affected
- 1 unit
- About this recall
- RIVASTIGMINE TRANSDERMAL SYSTEM, Delivers 4.6 mg/24 hours, 30 systems per box, Rx Only, Distributed by: Alvogen, Inc., Morristown, NJ 07960. NDC 47781-304-03